Prescription drug · NDA
Duopa (Carbidopa and levodopa) NDC 0074-3012
Levodopa 20 mg/mL; Carbidopa hydrate 4.63 mg/mL · Suspension · Enteral · AbbVie Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0074-3012-07 | 0007430120700074301207 | 7 CARTRIDGE in 1 CARTON (0074-3012-07) / 100 mL in 1 CARTRIDGEMarketed from Jan 15, 2015 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Duopa
- Generic name (nonproprietary)
- carbidopa and levodopa
- Active ingredients
- Levodopa — 20 mg/mLCarbidopa hydrate — 4.63 mg/mL
- Dosage form
- Suspension
- Route
- Enteral
- Labeler
- AbbVie Inc.NDC labeler code 0074
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 203952
- Marketing start
- Listing expires
- Other FDA classes
- Aromatic (Chemical structure)
- Identifiers
- Product ID 0074-3012_3141c7d9-a3c8-4658-8a14-22182f452465SPL ID 3141c7d9-a3c8-4658-8a14-22182f452465SPL set ID 7066d371-dc6a-0d6f-7bed-e5dd4ee912daRxCUI 1599846, 1599852UNII 46627O600J, MNX7R8C5VOUPC 0300743012071
- Pharmacologic class
- Aromatic Amino Acid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N400074301207followed by a unit qualifier and the quantityPackage 00074-3012-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
DUOPA ® is indicated for the treatment of motor fluctuations in patients with advanced Parkinson’s disease. DUOPA is a combination of carbidopa (an aromatic amino acid decarboxylation inhibitor) and levodopa (an aromatic amino acid) indicated for the treatment of motor fluctuations in patients with advanced Parkinson’s disease ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 0074-3012
- What is NDC 0074-3012?
- 0074-3012 is the product NDC for Duopa, Levodopa 20 mg/mL; Carbidopa hydrate 4.63 mg/mL suspension, listed with the FDA by AbbVie Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Duopa (Carbidopa and Levodopa).
- What is the active ingredient?
- Levodopa, Carbidopa hydrate.
- Who is the labeler?
- AbbVie Inc., NDC labeler code 0074. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Duopa?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.